Beijing Xutang Biotech made a significant entry at London Tech Week 2026, introducing its innovative health management platform, FuDe, which merges traditional Chinese medicine (TCM) with advanced AI technology.
This year’s London Tech Week has attracted over 30,000 participants, focusing on sectors such as AI, quantum computing, and notably, life sciences. A highlight has been the Deep Tech Stage, where FuDe's introduction has drawn considerable attention. The platform aims to address the widespread issue of sub-health—conditions that do not meet clinical thresholds but negatively impact quality of life, such as fatigue and insomnia. FuDe's philosophy aligns with TCM’s preventive approach, emphasizing the importance of maintaining health before symptoms escalate.
Central to FuDe is its AI TCM Four-Diagnostic Device, which digitizes traditional diagnostic methods. By collecting data through facial and tongue analysis, along with voiceprint recognition, the system can generate personalized health reports in just a few minutes. This technology aims to make health assessments accessible and part of daily routines, thereby enhancing proactive wellness management.
FuDe also features a "Five in One" system for comprehensive health management, addressing lifestyle-related discomforts rather than specific diseases. This holistic approach integrates dietary recommendations, herbal teas, and personalized health interventions, creating a dynamic and interactive health management loop. As Zhou Ning, the company’s founder, notes, FuDe represents not just a product, but a philosophy of preventive wellness, aiming to harmonize Eastern medicinal wisdom with modern technology for global health solutions.